Cardiac sarcoidosis is an uncommon and frequently overlooked condition characterized by the formation of inflammatory granulomas within the heart tissue. This intricately connected aspect of sarcoidosis, a systemic inflammatory disorder impacting multiple organs, presents unique challenges when it involves the heart. The origin of cardiac sarcoidosis remains elusive, with suspicions pointing toward an abnormal immune response. Symptoms manifest diversely, ranging from arrhythmias and conduction abnormalities to heart failure. Pinpointing cardiac sarcoidosis necessitates a multifaceted diagnostic approach, incorporating clinical assessment and advanced imaging techniques such as cardiac MRI or PET scans, occasionally augmented by cardiac biopsy. Timely identification is paramount, given the potential for significant morbidity and mortality if left untreated. Treatment strategies typically involve immunosuppressive medications aimed at quelling inflammation and managing symptoms. In light of its rarity, fostering increased awareness and fostering collaborative efforts among healthcare professionals are imperative for enhancing early detection and effective management of cardiac sarcoidosis.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation